Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-05

Clinical Trial Update: DOSE Trial of Opioid Sparing Effect [Phase 1]

View source ↗

Summary

Phase 1 trial update on opioid-sparing effects of dexmedetomidine in mechanically ventilated, critically ill patients; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Duke University | Conditions: Dexmedetomidine, Mechanical Ventilation Complication | Phase 1 | Status: TERMINATED | Results posted: 2021-11-05